CCR8/CCL1 and CXCR3/CXCL10 axis-mediated memory T-cell activation in patients with recalcitrant drug-induced hypersensitivity
British Journal of Dermatology · 2025
DOI: 10.1093/bjd/ljae375 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Dermatology, 2025. Verfasst von Tsu-Man Chiu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Chung Shan Medical University Hospital, Taichung, Taiwan. Hauptthemen laut MEDLINE: Receptors, CXCR3, Chemokine CXCL10, Chemokine CCL1, Receptors, CCR8. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Science and Technology Council, Chang Gung Memorial Hospital, Chung Shan Medical University Hospital.
Abstract (Originalsprache)
Background
As a drug-induced hypersensitivity syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS) is potentially fatal. Most patients with DRESS recover within a few weeks; however, some patients may suffer from a prolonged disease course and develop autoimmune sequelae.
Objectives
To investigate the immune mechanism and therapeutic targets of patients with recalcitrant DRESS with a prolonged disease course.
Methods
Thirty-two patients with recalcitrant DRESS with a prolonged treatment course (≥ 8 weeks; ‘prolonged DRESS’), 28 patients with DRESS with a short treatment course (< 2 weeks; ‘short-duration DRESS’) and 26 healthy donors (HDs) were enrolled.
Results
Bulk transcriptome results showed that the mRNA expression levels of CCR8 and CXCR3 were significantly increased in blood samples from patients in the acute stage of prolonged DRESS [Padj = 1.50 × 10–9 (CCR8) and Padj = 2.60 × 10–4 (CXCR3), patients with prolonged DRESS compared with the HD group]. Serum and skin lesion concentrations of CCL1 and CXCL10 (ligands of CCR8 and CXCR3, respectively) were significantly increased in patients with prolonged DRESS compared with patients with short-duration DRESS. The results from high-parameter flow cytometry and autoantibody screening also identified significant increases in CD8+ GNLY+ CXCR3+ effector memory T cells, CD8+ central memory T cells, CD4+ CCR8+ T helper 2 cells and IgG anti-HES-6 autoantibodies in patients with prolonged DRESS. Furthermore, in vitro blocking assays revealed that Janus kinase inhibitors (JAKi; mainly tofacitinib and upadacitinib) significantly decreased the release of CCL1 and CXCL10. Some patients with prolonged DRESS were successfully treated with JAKi.
Conclusions
JAKi (tofacitinib and upadacitinib) were associated with decreased concentrations of CCL1 and CXCL10, suggesting that they may attenuate CCR8/CCL1 and CXCR3/CXCL10 axis-mediated memory T-cell activation, which contributes to disease pathogenesis in patients with recalcitrant DRESS and a long-term treatment course. Graphical Abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Chung Shan Medical University Hospital, Taichung, Taiwan.
- Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
- School of Medicine, Chung Shan Medical University, Taichung, Taiwan.
- Department of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Linkou, Taipei, Tucheng and Keelung, Taiwan.
- Chang Gung Immunology Consortium, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan.
- Department of Dermatology, Xiamen Chang Gung Hospital, Xiamen, China.
ORCID-Profile: Chun-Bing Chen, Chuang-Wei Wang, Wen-Hung Chung
Förderung
- National Science and Technology Council
- Chang Gung Memorial Hospital
- Chung Shan Medical University Hospital
Zitieren
APA
Chiu, T. M., Chen, C. B., Lu, C. W., Hui, R. C., Chi, M. H., Chang, Y. C., Wu, J., Chen, K. Y., Lin, Y. Y., Lo, P. C., Hsu, T. C., Wang, C. W., & Chung, W. H. (2025). CCR8/CCL1 and CXCR3/CXCL10 axis-mediated memory T-cell activation in patients with recalcitrant drug-induced hypersensitivity. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljae375
Vancouver
Chiu TM, Chen CB, Lu CW, Hui RC, Chi MH, Chang YC, et al. CCR8/CCL1 and CXCR3/CXCL10 axis-mediated memory T-cell activation in patients with recalcitrant drug-induced hypersensitivity. British Journal of Dermatology. 2025. doi:10.1093/bjd/ljae375
BibTeX
@article{Chiu2025,
author = {Chiu, Tsu-Man and Chen, Chun-Bing and Lu, Chun-Wei and Hui, Rosaline Chung-Yee and Chi, Min-Hui and Chang, Ya-Ching and Wu, Jennifer and Chen, Kuan-Yu and Lin, Yang Yu-Wei and Lo, Pei-Chi and Hsu, Tsai-Ching and Wang, Chuang-Wei and Chung, Wen-Hung},
title = {CCR8/CCL1 and CXCR3/CXCL10 axis-mediated memory T-cell activation in patients with recalcitrant drug-induced hypersensitivity},
journal = {British Journal of Dermatology},
year = {2025},
doi = {10.1093/bjd/ljae375}
}
EUVIMED